Pharmaceutical Accountability Foundation

Pharmaceutical Accountability Foundation

Striving for equal access to medicines and medical technologies

Access to medicines is a human right

At Pharmaceutical Accountability Foundation, we believe the pharmaceutical industry has to be held accountable when they limit needed access by raising prices to unsustainable levels in pursuit of unfair profits. We therefore investigate cases of pharmaceutical company abuse of market exclusivity rights to keep prices high at the expense of public health. We then work to inform the public, or take legal action if necessary.


Why is medical technology so very expensive? There are many issues in the way we currently incentivise innovation.


There are several legal and policy solutions to stop misconduct, high prices, and limited access to medicines.


Examples of excessive pricing we have marked for investigation, or find illustrative of systemic challenges.

Recent News

Looking back at the Expert Panel Discussion on GCCP

On Thursday, 30 september, we hosted our event 'Discussing pharmaceutical human rights accountability during Covid-19'. We look back on a fruitful and engaging international expert...

First newsletter is out

The Pharmaceutical Accountability Foundation has kicked off its periodical newsletter, the very first has been sent out just now. And many more to follow as...

EVENT: Discussing pharmaceutical human rights accountability during Covid-19

An International Expert Panel Discussion on Good Covid-19 Company Practices (GCCP) The Pharmaceutical Accountability Foundation is organising an event on its Good Covid-19 Company Practices (GCCP)...

Dutch Competition Authority ACM honors PAFs enforcement request and fines pharmaceutical company Leadiant with €19.5 million

Bergeijk, July 19, 2021 On September 7, 2018, the Pharmaceutical Accountability Foundation (PAF) submitted an enforcement request  for abuse of a dominant market position by the...

Recent Tweets

Farma bedrijven én rijke landen breken alle beloften wat betreft vaccin verdeling aan niet-rijke landen. Toegang tot medicijnen is een mensenrecht, geen privilege.
FtV roept covid-19 farmaceuten ter verantwoording in onze #GCCPscorekaart via @NOS

Pharmaceutical companies and rich nations delivering just one in seven of the doses promised for developing countries shows a report by the @peoplesvaccine Alliance.

Load More...